Matrix metalloproteinase-26, a novel MMP, is constitutively expressed in the human intervertebral disc in vivo and in vitro

详细信息    查看全文

• 作者：Helen E. Gruber ; ^{helen.gruber@carolinashealthcare.org} ; Gretchen L. Hoelscher ; Jane A. Ingram ; Edward N. Hanley Jr.
• 关键词：MMP-26 ; Intervertebral disc ; Extracellular matrix remodeling ; Immunohistochemistry ; Gene expression
• 刊名：Experimental and Molecular Pathology
• 出版年：2012
• 出版时间：February, 2012
• 年：2012
• 卷：92
• 期：1
• 页码：59-63
• 全文大小：1124 K

文摘

Matrix metalloproteinase (MMP) regulation and expression is important in the aging/degenerating human intervertebral disc. MMP-26 (also known as matrilysin-2 or endometase) is a newly discovered MMP which degrades type IV collagen, fibronectin, fibrinogen, vitronectin, denatured collagen types I-IV, insulin-like growth factor binding protein 1, and activated pro-MMP-9. Our objective here was to determine if it is present in human disc tissue and cultured disc cells. Immunohistochemistry and microarray gene expression analyses were used to evaluate the presence of MMP-26 in human disc tissue from healthy and degenerated discs. Immunohistochemistry was also applied to human annulus cells cultured in a collagen sponge. Cellular and matrix localization of MMP-26 was identified in the outer and inner annulus and in the nucleus pulposus. Fewer cells showed localization in the inner vs. outer annulus, and localization was sparse in the nucleus. During in vitro culture of annulus cells, MMP-26 was also expressed. Molecular analyses showed significant downregulation of expression of MMP-26 (p = 0.03), and significant 9.8-fold upregulation of TGF-beta (p = 0.01) in more degenerated discs vs. healthier discs. Findings document the first identification of MMP-26 in the disc at the molecular and protein levels. Results point to the potentially important role of MMP-26 in matrix modulation during disc health and degeneration.